ZappRx CEO Zoë Barry named to LinkedIn's Next Wave Top Professionals Under 35

October 12, 2016

The process of filling a prescription for a specialty drug can be incredibly time consuming and complex, requiring reams of paperwork from healthcare providers. Zoe Barry, a 31-year-old Wall Street veteran, became interested in tackling those inefficiencies after her younger brother was diagnosed with severe epilepsy.


The ZappRx software platform is designed to automate and speed up the prescribing process by creating a secure digital platform that allows more transparency for doctors, pharmacists and patients. Since its founding in 2012, the company has raised $14 million in funding and has grown to a team of 20. The healthcare industry can be slow to innovate and ZappRx has been scaling its offering indication by indication, expanding from pulmonary to neurology and rheumatology. “Early on, any opposition was like fuel for my fire,” Barry says.

Barry’s used to working hard and dealing with a tough market; she worked as a raptor vet in Alaska and later interned in a neuroscience primate research lab at Harvard.

Watch now: What Barry sees as the biggest problem in specialty drugs — and how to solve it.